The Epidemiology and Genetics of Lung Cancer Research Program at Mayo Clinic engages in research to improve the detection and treatment of lung cancer and help improve the quality of life in lung cancer survivors.
Today, more people die of lung cancer than from any other forms of cancer combined. However, little significant improvement has been made on how to cure lung cancer in an advanced stage, and unfortunately, the majority of lung cancer patients are diagnosed with advanced disease.
Mayo Clinic researchers have discovered that some inherited factors can influence the course of lung cancer, including response to treatment, disease progression, development of new cancer, survival and quality of life of the patients.
Over the past decade, thousands of lung cancer patients and their relatives have taken part in lung cancer studies through the Epidemiology and Genetics of Lung Cancer Research Program. This has enabled clinicians and researchers to carry out long-term, in-depth studies of disease etiology and patient outcome.
The basic aim of the Epidemiology and Genetics of Lung Cancer Research Program is to find people who are at high risk of developing lung cancer through better understanding of how genes or traits can be easily tested to guide treatment for each patient, and to improve survival and quality of life among lung cancer patients.
While our purposes are to better understand the causes and natural history of lung cancer, our ultimate goals are to improve early detection, develop patient-specific treatment plans and help patients achieve a better quality of life.